Coagulation disorders and hemorrhagic shock in the parturient.
D000037:Abruptio Placentae / Q000150:complications; D058186:Acute Kidney Injury / Q000150:complications; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001803:Blood Transfusion; D004619:Embolism, Amniotic Fluid / Q000150:complications; D005260:Female; D005340:Fibrinogen / Q000494:pharmacology; D005341:Fibrinolysin / Q000494:pharmacology; D005342:Fibrinolysis; D006801:Humans; D006828:Hydatidiform Mole / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D009336:Necrosis; D007744:Obstetric Labor Complications; D010102:Oxygen Inhalation Therapy; D010288:Parenteral Nutrition; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011250:Pregnancy Complications, Hematologic; D011251:Pregnancy Complications, Infectious; D018805:Sepsis / Q000150:complications; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000209:etiology*; D013924:Thrombophlebitis / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D005340:Fibrinogen; D005341:Fibrinolysin